EMA recommends Moderna’s combined mRNA vaccine for protecting older adults against COVID-19 and flu
On Feb. 27, 2026, the European Medicines Agency (EMA) announced it’s recommending marketing authorization for mCombriax, Moderna’s combined…
-
-
first side-by-side comparison of how three major COVID-19 vaccines trigger immune responses
On Dec. 2, 2025, a Northwestern Medicine led study provided the first side-by-side comparison of how three major…
-
CDC reported effectiveness of COVID-19 Pfizer-BioNTech BNT162b2 mRNA vaccination in preventing COVID-19 among children and adolescents
On Mar. 1, 2022, the U.S. Centers for Disease Control and Prevention (CDC) reported that two doses of Pfizer-BioNTech…
